Ligand Pharmaceuticals Inc
LGND
Revenue
59.67M
▼-55.80M▼-48.32%
3 Months ChangeAssets
1.56B
▲83.87M▲5.68%
3 Months ChangeLiabilities
543.43M
▲16.82M▲3.19%
3 Months ChangeFree Cash Flow
-25.66M
▼-44.29M▼-237.75%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0000886163-26-000003
2025-12-18
Form 8-K
ID: 0001193125-25-324830
2025-11-07
Form 10-Q
ID: 0000886163-25-000063
2025-11-06
Form 8-K
ID: 0000886163-25-000058
2025-09-16
Form 8-K
ID: 0001193125-25-205147
2025-08-14
Form 8-K
ID: 0001193125-25-180841
2025-08-11
Form 8-K
ID: 0001193125-25-177452
2025-08-08
Form 10-Q
ID: 0000886163-25-000051
2025-08-07
Form 8-K
ID: 0000886163-25-000047
2025-07-02
Form 8-K
ID: 0000886163-25-000042